Skip to main
DLB
DLB logo

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. reported total revenues of $307.0 million, reflecting a year-over-year increase of approximately 1%, while full-year total revenue rose 5.9% with significant contributions from licensing revenue (up 5.6%) and product/services revenue (up 10%). The company's operating margins improved to 33.2%, up from 31.2%, indicating enhanced profitability alongside revenue growth. Furthermore, the adoption of Dolby's technologies, including its SaaS-like models for patent licensing and increasing demand for Dolby Vision capture in key markets like China and India, underscores the potential for sustainable growth in a competitive industry.

Bears say

Dolby Laboratories is projecting a revenue decline in fiscal 2026, with expectations of a high-single-digit decrease, mirroring trends observed in fiscal 2025. Management has also revised growth expectations for its Atmos/Vision/Patents business downward to 15% to 20%, reflecting a cautious outlook on future revenues. Additionally, gross margins have contracted to 89.7% from 90.1%, indicating potential pressures on profitability amid ongoing market challenges and declining device volumes linked to a post-pandemic environment.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Dec 13, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.